The Docusate Sodium Capsules, cataloged under National Stock Number 6505-00-809-0241, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Marlex Pharmaceuticals Inc Dba Marlex Pharmaceuticals I. Government technical data includes 4 specifications, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 1 additional reference document (drawings, advisory and superseded references) is recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-00-809-0241 |
| Primary Part Number | NDC10135-0111-10 |
| Item Name | Docusate Sodium Capsules |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Marlex Pharmaceuticals Inc Dba Marlex Pharmaceuticals I |
| Status | ACTIVE |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Capsule Primary Container Content Quantity | 1000.000 |
| Active Medicament Medicinal Strength | 100.000 MILLIGRAMS DOCUSATE SODIUM ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC10135-0111-10 PRIMARY | Marlex Pharmaceuticals Inc Dba Marlex Pharmaceuticals I (USA) |
| NDC57896040110 PRIMARY | Geri-Care Pharmaceuticals Corp. (USA) |
| Reference | Meaning |
|---|---|
| 00904788980 | 5/9 Secondary reference Major Pharmaceuticals Inc |
NSN 6505-00-809-0241 is a Docusate Sodium Capsules, manufactured by Marlex Pharmaceuticals Inc Dba Marlex Pharmaceuticals I, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-00-809-0241 has 2 manufacturer part numbers on file: NDC10135-0111-10 (Marlex Pharmaceuticals Inc Dba Marlex Pharmaceuticals I), NDC57896040110 (Geri-Care Pharmaceuticals Corp.).
Key specifications for NDC10135-0111-10: Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE; Capsule Primary Container Content Quantity: 1000.000; Part Name Assigned by Controlling Agency: DOCUSATE SODIUM CAPSULES USP 100MG 1000S BT. 4 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.